KME-3859

N/A

Report date: 2023/02/13 17:52:18

Base Information

Drug NameKME-3859
Drug Alias NameKME-3859
ClassificationOther
Mechanisms of ActionInterleukin-1 receptor-associated kinase 1 inhibitors
TargetsInterleukin-1 receptor-associated kinase 1
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCincinnati Children'S Hospital Medical CenterNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKurome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A